Chinese Humanoid Robot Companies (2026): The Players Western Media Under-Covers

In January 2026, research firm Omdia released its first global ranking of humanoid robot shipments. The top three names were all Chinese. According to Forbes, 87% of all humanoid robots delivered in 2025 were made in China, primarily by just two companies: AgiBot and Unitree.

This is not widely understood in the West. Most English-language tech coverage focuses on Tesla Optimus, Figure AI, and Boston Dynamics. These are important companies, but they are not where the majority of actual shipments come from. China dominates humanoid manufacturing today, backed by government policy, massive venture capital, and a manufacturing ecosystem centered around Shenzhen that can iterate hardware faster than anywhere else.

This guide profiles the major Chinese humanoid robot companies, what they make, what they cost, and where they are deployed.

The landscape at a glance

Company	Founded	Total Funding	Key Product	Est. Shipments (2025)	Status
AgiBot	2023	~$1B+	Multiple models	~5,168	Shipping
Unitree	2016	$246M+	G1, H2	~5,500	Shipping
Galbot	2023	~$700M+	Galbot series	Unknown	Shipping
UBTech	2012	$940M+ (IPO)	Walker, UWORLD U1	Unknown	Shipping
Fourier Intelligence	2015	$100M+	GR-2	Unknown	Shipping
LimX Dynamics	2022	Unknown	CL-1, CL-2	Unknown	Shipping

Important caveat: shipment numbers in this industry are disputed and often unverified. AgiBot and Unitree both claim top positions depending on counting methodology (per Omdia’s January 2026 report). “Shipped” does not always mean “autonomously performing useful work,” it may include units in research labs, pilot programs, or internal testing.

AgiBot (智元机器人)

Founded: 2023 (Shanghai) Funding: Over $1 billion (estimated from multiple rounds, exact total not publicly confirmed) Key fact: Estimated market leader by shipments alongside Unitree

AgiBot is remarkable for its speed. Founded in 2023, it reached the top of global humanoid shipment rankings by early 2026, condensing years of typical startup growth into months. The company makes multiple humanoid models for different industrial applications.

Forbes reported that “Galbot and Agibot, both founded in 2023, have already raised a combined total of nearly $2 billion.” This funding velocity reflects how seriously Chinese investors and government policy take humanoid robotics.

AgiBot was reported to have dropped its U.S. launch of three models, suggesting geopolitical and market-access considerations are already affecting the industry.

What they ship: Industrial humanoids for manufacturing and logistics Where they deploy: Chinese factories and warehouses primarily Western coverage gap: AgiBot is rarely mentioned in mainstream English-language tech publications despite being the global shipment leader

Unitree (宇树科技)

Founded: 2016 (Hangzhou) Funding: $246M+ total Key products: G1 ($13,500), H2 ($29,900) IPO status: Rushing to list per CNBC (July 2026)

Unitree is the most visible Chinese humanoid company in the West, primarily because of their aggressive pricing and direct-to-buyer sales model. Their robots are orderable internationally through their website and through resellers like Robozaps.

Unlike many competitors that sell primarily to Chinese industry, Unitree has cultivated a global developer community. Their G1 is the de facto standard research humanoid in universities worldwide because of its $13,500 price point.

Unitree is also notable for its earlier quadruped (dog-like) robots, which established the company’s manufacturing expertise before pivoting to humanoids.

Strengths: Lowest prices, international availability, growing developer community, IPO-track validates business model Limitations: Q1 2026 profit fell by half despite growing shipments (per Technology.org), suggesting aggressive pricing is eating into margins

For a detailed comparison with Western competitors, see our Unitree vs Figure vs Tesla Optimus article.

Galbot (星尘智能)

Founded: 2023 (Shenzhen) Funding: ~$700M+ (including a 2.5 billion yuan round in March 2026) Key fact: Highest-valued unlisted humanoid robotics firm in China

Galbot’s March 2026 funding round was notable for including China’s national AI industry investment fund, China Petroleum & Chemical Corp (Sinopec), and CITIC Investment Holdings. This marks the first time a national-level fund invested in an embodied intelligence company in China, signaling top-level government backing.

The company focuses on embodied intelligence, combining physical hardware with AI that learns from interaction. Their funding trajectory ($700M+ raised in under 3 years from founding) is extraordinary even by Chinese venture capital standards.

What they ship: Embodied intelligent robots for industrial and commercial applications Western coverage gap: Almost no English-language coverage despite being the highest-funded Chinese humanoid startup. The AI Insider and Global Times are among the few English sources covering their funding rounds.

UBTech (优必选)

Founded: 2012 (Shenzhen) Funding: $940M+ pre-IPO, then Hong Kong IPO (December 2023) Key products: Walker series, UWORLD U1 IPO status: Publicly traded on HKEX

UBTech is the most established Chinese humanoid company, having been in the space since 2012. They are publicly traded (the first humanoid robot company to IPO globally) and have the longest track record.

In July 2026, UBTech launched the UWORLD U1 Series at their Global Launch Event in Shenzhen. They describe it as “the world’s first full-size mass-produced ultra-bionic humanoid robot,” designed for mass production rather than one-off research units. The launch included their long-term vision for “human-robot symbiosis.”

Strengths: Longest track record, publicly traded (financial transparency), diverse product line (consumer to industrial), early mover in mass production claims Limitations: Older company with more conservative innovation pace than AgiBot/Galbot

Fourier Intelligence (傅利叶智能)

Founded: 2015 (Shanghai) Key product: GR-2 general-purpose humanoid Background: Originally a rehabilitation robotics company, pivoted to general-purpose humanoids

Fourier Intelligence brings a unique background: they started in medical rehabilitation robots (exoskeletons and therapy devices), giving them deep expertise in precise human-like motion and safety around people. Their GR-2 humanoid leverages this rehabilitation background for smooth, human-safe movement.

Strengths: Safety expertise from medical robotics background, human-like motion quality, diverse application targets (healthcare + general purpose) Limitations: Less venture funding than AgiBot/Galbot, smaller production scale

LimX Dynamics (逐际动力)

Founded: 2022 (Shenzhen) Status: Rushing to IPO per CNBC (July 2026) Focus: Dynamic locomotion and whole-body control

LimX is the newest entrant but already attracting attention for their locomotion capabilities. CNBC reported in July 2026 that they are among Chinese humanoid startups rushing to list, alongside Unitree.

Their focus is more narrowly on locomotion and dynamics (making robots walk, run, and balance well) rather than full-stack humanoid intelligence. This specialization may make them an attractive component provider or acquisition target.

The funding landscape

Chinese humanoid robotics funding is in a class of its own:

Total sector: $9.8 billion cumulative VC funding by end of 2025
Growth: 2026 Q1 funding up 288% year-over-year
Market revenue: ~$4.89 billion in 2025, projected $6.24 billion in 2026
Gap: Funding ($9.8B+) exceeds revenue ($4.89B) by roughly 2:1, suggesting the sector is still investment-driven rather than profit-driven

The funding-to-revenue gap means these companies are collectively spending more on development than they are earning from sales. This is sustainable only as long as investor confidence (and government policy support) holds. It creates risk for individual companies but accelerates the entire category’s development speed.

Government backing

China’s humanoid robotics push is not just market-driven. Government policy explicitly targets humanoid robots as a strategic technology:

National-level AI funds are directly investing (Galbot’s March 2026 round)
State-owned enterprises (Sinopec, CITIC) are anchor investors
Production targets for humanoid deployment in manufacturing and logistics exist at both national and provincial levels
Government procurement provides a guaranteed domestic market

This means Chinese humanoid companies operate with a funding floor that Western competitors (who rely purely on venture capital and commercial customers) do not have. Even if commercial demand is slower than expected, government support can bridge the gap.

Why this matters for the global industry

The Chinese dominance in actual humanoid shipments (87% globally per Forbes) creates several dynamics:

Price competition. Unitree’s $13,500 G1 sets a floor that Western companies must compete with. Figure and Tesla cannot price significantly above this without a compelling quality or capability justification.

Speed of iteration. Chinese companies iterate hardware faster because of the Shenzhen manufacturing ecosystem: rapid prototyping, cheap components, experienced factory labor. AgiBot went from founding to market leader in under 3 years.

Information asymmetry. Most of what these companies publish is in Chinese. Their WeChat announcements, technical papers, and product updates reach Chinese developers first and may never be translated. Following this space purely through English-language sources means missing significant developments.

Geopolitical risk. AgiBot dropping its U.S. launch signals that market access is not guaranteed. Export controls, tariffs, and geopolitical tensions could fragment the market into Chinese and Western ecosystems with limited interoperability.

How to follow Chinese robotics

If you want to stay current on this space:

Omdia publishes quarterly humanoid shipment rankings
CNBC covers the IPO and business side of Chinese humanoid startups
Forbes (Edith Yeung) covers Chinese AI/robotics venture capital
Global Times and Pandaily cover Chinese funding rounds in English
WeChat accounts of individual companies (requires Chinese language)
Physical AI Field (this site) will track Chinese robotics as a permanent coverage area

FAQ

Which Chinese company makes the most humanoid robots?

AgiBot and Unitree are both estimated at roughly 5,000-5,500 units shipped in 2025, making them the global leaders. The exact ranking is disputed depending on counting methodology.

Can I buy a Chinese humanoid robot outside China?

Yes. Unitree sells internationally through their website and resellers like Robozaps. UBTech and Fourier have international sales channels. AgiBot and Galbot are primarily China-focused currently.

Are Chinese humanoid robots as capable as Tesla Optimus or Figure?

Different capabilities at different price points. Chinese robots (Unitree especially) prioritize affordability and availability. Western competitors (Figure, Tesla) prioritize advanced AI and specific industrial capabilities. The “best” depends on whether you value having hardware today at a low price (Chinese advantage) or having frontier AI capabilities in the future (Western advantage, if they deliver).

Why is China ahead on humanoid shipments?

Government backing (funding floor, guaranteed procurement), manufacturing ecosystem speed (Shenzhen), aggressive pricing, and a cultural willingness to ship imperfect hardware and iterate (vs. Western companies that often wait for perfection before shipping).

Is Chinese humanoid robot funding sustainable?

The $9.8B funding vs $4.89B revenue gap suggests the sector is currently investment-driven. This is sustainable as long as government policy support continues and investors maintain confidence. If either wavers, some companies will fail. But the largest players (AgiBot, Unitree, UBTech) have enough backing to survive a correction.